Total 1077 thoracic ESCC patients who had undergone esophagectomy and lymphadenectomy were retrospectively examined. The clinicopathologic factors related to lymph node metastasis were analyzed using logistic regression analysis.
The rates of lymph node metastases in patients with upper thoracic tumors were 16.7 % (9/54) cervical, 38.9 % (18/54) upper mediastinal, 11.1 % (6/54) middle mediastinal, 5.6 % (3/54) lower mediastinal, and 5.6 % (3/54) abdominal, respectively. The rates of lymph node metastases in patients with middle thoracic tumors were 4.0 % (27/680), 3.8 % (26/680), 32.9 % (224/680), 7.1 % (48/680), and 17.1 % (116/680), respectively. The rates of lymph node metastases in patients with lower thoracic tumors were 1.0 % (5/343), 3.0 % (10/343), 22.7 % (78/343), 37.0 % (127/343), and 33.2 % (114/343), respectively. T stage, the length of tumor and the histological differentiation emerged as statistically significant risk factors of lymph node metastases of thoracic ESCC (P < 0.001).
T stage, the length of tumor and the histologic differentiation influence the pattern of lymph node metastases in thoracic ESCC. These factors should be considered comprehensively to design the CTV for radiotherapy (RT) of thoracic ESCC. Selective regional irradiation including the correlated lymphatic drainage regions should be performed as well.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址:北京市海淀区学院路29号 邮编:100083 电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700 |